Schedule II - Condensed Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Assets
Fixed maturities, available-for-sale, at fair value	$ 253,152	$ 281,001
Cash and cash equivalents	198,762	137,036
Accrued investment income	3,156	2,964
Other assets	11,998	16,816
Assets held for sale	0	73,243
Total Assets	1,072,732	1,216,112
Liabilities
Accounts payable and accrued expenses	112,781	86,140
Notes payable	149,353	149,020
Total Liabilities	755,167	980,452
Stockholders' Equity
Common stock	5	5
Additional paid-in capital	439,742	436,524
Treasury shares	(431)	(431)
Accumulated other comprehensive loss	(7,242)	(15,666)	$ (17,137)	$ (30,947)
Retained earnings (deficit)	(114,509)	(184,772)
Total Stockholders' Equity	317,565	235,660	$ 168,765	$ (182,039)
Total Liabilities and Stockholders' Equity	1,072,732	1,216,112
Parent Company [Member]
Assets
Fixed maturities, available-for-sale, at fair value	1,964	1,454
Other Investments	125	118
Cash and cash equivalents	32,394	34,377
Accrued investment income	108	114
Investment in subsidiaries	462,589	477,072
Other assets	52,436	45,461
Assets held for sale	0	775
Total Assets	549,616	559,371
Liabilities
Intercompany payable	40,897	150,012
Accounts payable and accrued expenses	41,801	24,679
Notes payable	149,353	149,020
Total Liabilities	232,051	323,711
Stockholders' Equity
Common stock	5	5
Additional paid-in capital	439,742	436,524
Treasury shares	(431)	(431)
Accumulated other comprehensive loss	(7,242)	(15,666)
Retained earnings (deficit)	(114,509)	(184,772)
Total Stockholders' Equity	317,565	235,660
Total Liabilities and Stockholders' Equity	$ 549,616	$ 559,371